Related Experiment Video
Updated: Jul 19, 2026

Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
Published on: February 22, 2017
The type II signal peptidase of Legionella pneumophila
Nick Geukens1, Emmy De Buck, Eef Meyen
1Laboratory of Bacteriology, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium.
Abstract:
Legionella pneumophila is a facultative intracellular Gram-negative bacterium that has become an important cause of community-acquired and nosocomial pneumonia. Recent studies concerning the unravelling of bacterial virulence have suggested the involvement of protein secretion systems in bacterial pathogenicity. In this respect, the type II signal peptidase (LspA), which is specifically required for the maturation of lipoproteins, is of particular interest. This paper reports the cloning and functional characterization of the L. pneumophila lspA gene encoding the type II signal peptidase (SPase II). Activity of the L. pneumophila LspA was demonstrated using a globomycin sensitivity assay in Escherichia coli. In L. pneumophila, the lspA gene is flanked by the isoleucyl-tRNA synthetase (ileS) gene and the gene encoding a 2-hydroxy-3-deoxy-phosphogluconate aldolase. Although there is no apparent physiological connection, transcriptional analysis demonstrated that, as in some other Gram-negative bacteria, lspA is cotranscribed with ileS in L. pneumophila. Finally, in silico analysis revealed that several proteins known to be crucial for virulence and intracellular growth of L. pneumophila are predicted to be lipoproteins. These include, in particular, proteins involved in protein secretion and motility. Results obtained strongly suggest an important role for LspA in the pathogenicity of L. pneumophila, making it a promising new target for therapeutic intervention.
Insights
The type II signal peptidase (LspA) is crucial for Legionella pneumophila pathogenicity. This study characterizes the LspA gene, revealing its role in lipoprotein maturation and suggesting LspA as a therapeutic target for pneumonia.
Area of Science:
- Microbiology
- Molecular Biology
- Bacterial Pathogenesis
Background:
- Legionella pneumophila causes community-acquired and nosocomial pneumonia.
- Protein secretion systems are implicated in bacterial virulence.
- Type II signal peptidase (LspA) is essential for lipoprotein maturation.
Purpose of the Study:
- To clone and functionally characterize the L. pneumophila lspA gene.
- To investigate the role of LspA in L. pneumophila pathogenicity.
- To explore LspA as a potential therapeutic target.
Main Methods:
- Cloning and functional characterization of the L. pneumophila lspA gene.
- Globomycin sensitivity assay in Escherichia coli to assess LspA activity.
- Transcriptional analysis to determine lspA gene organization and cotranscription.
- In silico analysis to predict lipoprotein presence in L. pneumophila.
Main Results:
- The L. pneumophila lspA gene encoding type II signal peptidase (SPase II) was cloned and characterized.
- LspA activity was confirmed using a globomycin sensitivity assay.
- lspA is cotranscribed with the isoleucyl-tRNA synthetase (ileS) gene.
- In silico analysis predicted several crucial virulence proteins as lipoproteins.
Conclusions:
- LspA plays a significant role in the pathogenicity of Legionella pneumophila.
- The characterized lspA gene and its encoded protein are promising targets for novel therapeutic interventions against L. pneumophila infections.
Related Concept Videos
Atypical Pneumonia
Gene Regulation in Microbial Communities: Quorum Sensing
Amplifying Signals via Enzymatic Cascade
Regulation of Bacterial Virulence
Gram-negative Bacterial Protein Secretion Systems
